Search Within

Elisa De Stanchina

  1. "Cancer Research"
Formats
  1. Meeting Abstract (41)
  2. Journal Article (11)
Groups
  1. GSK Faculty (45)
  2. Sloan Kettering Institute Postdocs (36)
  3. Department of Medicine (35)
  4. Solid Tumor Oncology Division (34)
  5. Human Oncology and Pathogenesis Program (25)
  6. Sloan Kettering Institute Faculty (23)

More Groups

People
  1. Neal Rosen (12)
  2. Charles Rudin (9)
  3. Marc Ladanyi (7)
  4. Sarat Chandarlapaty (7)
  5. Triparna Sen (7)
  6. Amanda Kulick (6)

More People

Years
  1. 2025 (2)
  2. 2022 (15)
  3. 2021 (6)
  4. 2020 (4)
  5. 2019 (2)
  6. 2018 (5)

More Years

Publications
  1. Cancer Research (52)
Publishers
  1. American Association for Cancer Research (52)

Results (52)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SCD1 inhibition blocks the AKT–NRF2–SLC7A11 pathway to induce lipid metabolism remodeling and ferroptosis priming in lung adenocarcinoma
    Journal Article

    Sen, U.; Coleman, C.; Gandhi, N.; Jethalia, V.; Demircioglu, D.; Elliott, A.; Vanderwalde, A. M.; Hayatt, O.; de Stanchina, E.; Halmos, B.; more...
    Cancer Research (2025)

    Fulltext@MSK | Save
  • Tumorigenesis driven by BRAF(V600E) requires secondary mutations that overcome its feedback inhibition of RAC1 and migration
    Journal Article

    Gadal, S.; Boyer, J. A.; Roy, S. F.; Outmezguine, N. A.; Sharma, M.; Li, H.; Fan, N.; Chan, E.; Romin, Y.; Barlas, A.; more...
    Cancer Research (2025)

    Fulltext@MSK | Save
  • Estrogen receptor expression and ER dependent breast tumor growth are dependent on translation initiation factor EIF4A
    Meeting Abstract

    Boyer, J. A.; Dorso, M. A.; Amor, C.; Reiter, J.; Xu, J.; de Stanchina, E.; Wendel, H. G.; Chandarlapaty, S.; Rosen, N.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Development of a patient-derived xenograft (PDX) modeling program to enable pediatric precision medicine
    Meeting Abstract

    Dela Cruz, F. S.; McCarter, J. G.; You, D.; Bouvier, N.; Wang, X.; Guillan, K. C.; Siddiquee, A. H.; Souto, K. B.; Li, H.; Gao, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Frequent 4EBP1 amplification induces synthetic dependence on FGFR signaling in cancer
    Meeting Abstract

    Singh, K.; Mohan, P.; Sanghvi, V. R.; Ciriello, G.; Lailler, N.; de Stanchina, E.; Wendel, H. G.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC
    Meeting Abstract

    Caeser, R.; Hulton, C.; Costa, E.; Durani, V.; Little, M.; Chen, X.; Tischfield, S. E.; Asher, M.; Kombak, F. E.; Chavan, S. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Exportin 1 inhibition as a therapeutic strategy for small cell lung cancer
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y. A.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N. S.; Bhanot, U. K.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Migration of V600E-expressing cells is suppressed by ERK-dependent feedback inhibition of RAC1 and rescued in melanoma by secondary mutations
    Meeting Abstract

    Gadal, S.; Boyer, J. A.; Li, H.; Fan, N.; Chan, E.; Romin, Y.; De Stanchina, E.; Yeager, R.; Bosenberg, M.; Todorova, K. M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Multiomic profiling of patient-derived xenografts established from patients with malignant pleural mesothelioma proposes pathways associated with poor prognosis
    Meeting Abstract

    Offin, M.; Sauter, J. L.; Egger, J. V.; deStanchina, E.; Poirier, J. T.; Zauderer, M. G.; Rudin, C.; Sen, T.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Reversibility of tumor adaptations to PI3K inhibition decreases as a function of time
    Meeting Abstract

    Mukherjee, R.; de Stanchina, E.; Chandarlapaty, S.; Rosen, N.
    Cancer Research (2022)

    Fulltext@MSK | Save